US Edition‘Landmark study’ led by UNLV shows new path to treat, prevent autism
- A UNLV-led study led by professor Aukasz Sznajder discovered a new molecular pathway to autism and published it on April 21 in Nature Neuroscience.
- The research followed observations of high crossover between myotonic dystrophy, a genetic condition causing muscle weakness, and autism spectrum disorder.
- The study found that mutations in the DMPK gene, which causes myotonic dystrophy, also lead to mis-splicing of multiple autism-related genes, disrupting nervous system function.
- Around 60% to 90% of autism is genetic, and experts like Brumback and Sultan said the study identifies one mechanism among many, with Brumback calling it important for developing treatments targeting mis-splicing.
- This discovery may enable new diagnostic tools, screenings for autism in myotonic dystrophy patients, and future interventions despite ongoing debate about environmental contributions to autism.
21 Articles
21 Articles
Telomir Pharmaceuticals Demonstrates Telomir-1 Reverses Key Drivers of Cellular Decline in Human Cell Lines Supporting Therapeutic Potential in Autism and Spasmodic Dysphonia
MIAMI, FLORIDA / ACCESS Newswire / May 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir"), a leader in age-reversal science, today announced new preclinical data showing that its lead oral drug candidate, Telomir-1, reverses multiple hallmarks of cellular decline across…
Full-Spectrum CBD Drug for Autism Spectrum Disorder Poised for Phase 2 Clinical Trials in the US - Cannabis News World
DeFloria, a joint venture between Charlotte’s Web Holdings and Ajna BioSciences, is advancing toward the start of its Phase 2 clinical trial for AJA001, a cannabinoid-based (FDA) botanical drug developed to treat behavioral symptoms associated with autism spectrum disorder (ASD). The post Full-Spectrum CBD Drug for Autism Spectrum Disorder Poised for Phase 2 Clinical Trials in the US appeared first on Business of Cannabis.
Can Genetics Predict Autism Intellectual Disabilities?
A new predictive model combining genetics with developmental milestones may help forecast which autistic children are at risk of developing intellectual disabilities. In a large study of over 5,600 children, researchers were able to correctly predict 10% of such cases and differentiate between low and high-risk groups twice as well as current methods.
Prevalence and Characteristics of Adolescents with Autism Spectrum Disorder in the New York-New Jersey Metropolitan Area
Almost all epidemiologic studies estimating autism spectrum disorder (ASD) prevalence have focused on school-age children. This study provides the first po
Coverage Details
Bias Distribution
- 75% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
